Abstract:Curcumin (CUR) has attracted wide research interests due to its abundant bioactivities and potential advantages in cancer treatment. But the poor water solubility, instability, and quick metabolization and elimination after oral administration severely restrict the efficacy and further clinical application of CUR. Derivation is an approach often used to improve the druggability of active ingredients, so the study aim to prepare a CUR derivate with better stability, satisfactory pharmacokinetics, and inherent self-assembled ability in contrast with CUR. The derivate was designed and evaluated in vitro and in vivo. Vitamin E (VE) was used to perform the esterification reaction with CUR, and the cytotoxicity of derivative CUR-VE ester on MCF-7 tumor cells was similar to CUR. Besides the better stability in simulated gastric and intestinal fluid, plasma and liver homogenate, the self-assembly CUR-VE nanoparticles were fabricated by feasible and controllable nanoprecipitation method. The Transmission Electron Microscope (TEM) showed CUR-VE NPs were spherical with an average particle size of 172.9 nm, and drug loading was up to 93%. CUR-VE NPs exhibited a sustained-release behavior and fitted to Fick's diffusion mechanism. Differential Scanning Calorimeter (DSC), X-ray Powder Diffractometer (XRPD) and Fourier Transform Infrared Spectrometer (FTIR) declared no crystalline substances were formed, and the self-assembly process of CUR-VE relied on driving forces including van der Waals forces, hydrogen bonding forces, intermolecular forces. In pharmacokinetics, Cmax and AUC0-∞ of CUR-VE NPs by the route of oral administration were (104.69 ± 40.72) ng/mL and (3496.92 ± 1088.93) ng/mL*h, which were about three times and 18 times more compared with CUR. The eliminated half-time of CUR-VE extended to 28 h ascribed to the outstanding stability and surface PEGylation of NPs. It prompted that appropriately PEGylated NPs via oral administration was beneficial to prolong systemic circulation similar to intravenous PEGylated NPs.In summary, the study provides a convenient way to fabricate the self-assembled CUR-VE NPs qualified with high drug loading, satisfactory stability and desired pharmacokinetics. CUR-VE has the potent advantage to be an ideal substitute for CUR in the future of healthcare and clinical application.

Functionalization of Nanodiamond with Vitamin E TPGS to Facilitate Oral Absorption of Curcumin

Enhanced Oral Delivery of Curcumin Via Vitamin E TPGS Modified Nanodiamonds: a Comparative Study on the Efficacy of Non-covalent and Covalent Conjugated Strategies

Investigations on the Interactions Between Curcumin Loaded Vitamin E TPGS Coated Nanodiamond and Caco-2 Cell Monolayer

Enhanced oral bioavailability of self-assembling curcumin-vitamin E prodrug-nanoparticles by co-nanoprecipitation with vitamin E TPGS

N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations

Preparation, Characterization, Pharmacokinetics, and Tissue Distribution of Curcumin Nanosuspension with Tpgs As Stabilizer

Study on the Stability and Oral Bioavailability of Curcumin Loaded (-)-epigallocatechin-3-gallate/poly(n-vinylpyrrolidone) Nanoparticles Based on Hydrogen Bonding-Driven Self-Assembly

Preparation of curcumin-loaded MPEG-PTMC nanoparticles: Physicochemical properties, antioxidant activity, and in vivo pharmacokinetic behavior

BSA Nanoparticles Modified with N -Acetylcysteine for Improving the Stability and Mucoadhesion of Curcumin in the Gastrointestinal Tract.

In vivo evaluation of curcumin loaded nanosuspensions by oral administration.

Preparation and pharmacokinetics of curcumin nanostructured lipid carriers in rats

Enhancing Curcumin Oral Bioavailability Through Nanoformulations

Excogitation and Assessment of Curcumin-Vitamin E Self-assembly PEGylated Nanoparticles by the Route of Oral Administration

The Enhancement of N-acetylcysteine on Intestinal Absorption and Oral Bioavailability of Hydrophobic Curcumin.

Cationic Curcumin Nanocrystals Liposomes for Improved Oral Bioavailability: Formulation Development, Optimization, In Vitro and In Vivo Evaluation

Preparation of Pectin-Tannic Acid Coated Core-Shell Nanoparticle for Enhanced Bioavailability and Antihyperlipidemic Activity of Curcumin

Preparation and In-Vitro/in-vivo Evaluation of Curcumin Nanosuspension with Solubility Enhancement.

Encapsulation of Curcumin in a Ternary Nanocomplex Prepared with Carboxymethyl Short Linear Glucan-Sodium-Caseinate-Pectin Via Electrostatic Interactions

Oral Delivery of Curcumin Using Silk Nano- and Microparticles

N-trimethyl Chitosan Chloride-Coated Liposomes for the Oral Delivery of Curcumin.

Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers.